INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q4 2019
Shares 22,800 Value ($000) $2,825 Avg Close — Range —
Q3 2019
Shares 32,200 Value ($000) $2,137 Avg Close — Range —
Q4 2018
Shares 47,800 Value ($000) $4,818 Avg Close — Range —
Q3 2017
Shares 386,380 Value ($000) $22,425 Avg Close — Range —
Q2 2017
Shares 856,554 Value ($000) $103,703 Avg Close — Range —
Q1 2017
Shares 1,037,000 Value ($000) $117,285 Avg Close — Range —
Q4 2016
Shares 1,120,000 Value ($000) $121,688 Avg Close — Range —
Q3 2016
Shares 1,120,000 Value ($000) $184,341 Avg Close — Range —
Q2 2016
Shares 1,120,000 Value ($000) $159,802 Avg Close — Range —
Q1 2016
Shares 1,120,000 Value ($000) $143,886 Avg Close — Range —
Q4 2015
Shares 1,120,000 Value ($000) $167,272 Avg Close — Range —
Q3 2015
Shares 1,120,000 Value ($000) $185,763 Avg Close — Range —
Q2 2015
Shares 1,120,000 Value ($000) $270,346 Avg Close — Range —
Q1 2015
Shares 1,120,000 Value ($000) $315,862 Avg Close — Range —
Q4 2014
Shares 1,485,000 Value ($000) $231,660 Avg Close — Range —
Q3 2014
Shares 1,485,000 Value ($000) $351,485 Avg Close — Range —
Q2 2014
Shares 1,656,258 Value ($000) $391,298 Avg Close — Range —
Q1 2014
Shares 1,734,934 Value ($000) $572,164 Avg Close — Range —
Q4 2013
Shares 1,734,934 Value ($000) $118,461 Avg Close — Range —
Q3 2013
Shares 2,151,607 Value ($000) $148,525 Avg Close — Range —
Q2 2013
Shares 2,150,634 Value ($000) $96,434 Avg Close — Range —